This phenomenon suggests that pharmacological modulation or improvement of HDL metabolism could have potential benefits for the treatment of CKD
doi: 10.1016/j.agwat.2023.108237 88 NoorI.SohailH.AkhtarM
At Ageless Center, our integrative health approach evaluates the full metabolic picture, because weight loss, hormonal balance, and sexual health are not separate clinical tracks
The evidence hierarchy for this specific combination is thin
In the Phase 2 trial, the defined 1 mg weekly dose produced 8.7% mean weight loss over 48 weeks versus 2.1% with placebo clinically meaningful, but roughly a third of the 12 mg result (24.2%)
Retatrutide may eventually prove manageable in a similar way, but today it carries more uncertainty simply because it is newer and still investigational